We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
In The News: HPV jab success.
- Authors
Dell, Helen
- Abstract
The article focuses on vaccine targeting four strains of human papillomavirus (HPV). It has reduced infection rates by 90% compared with a placebo in a randomized, double-bline trial. The vaccine was purposefully designed to target the HPV types most commonly associated with cervical cancer, as well as types that cause genital warts and many abnormal pap smears, to reduce the burden from HPV infection as much as possible. The vaccine could have a huge impact if young girls are vaccinated in countries that don't have routine cervical cancer screening.
- Subjects
PAPILLOMAVIRUSES; VACCINES; CLINICAL trials; PLACEBOS; INFECTION; CERVICAL cancer; GENITAL warts
- Publication
Nature Reviews Cancer, 2005, Vol 5, Issue 5, p334
- ISSN
1474-175X
- Publication type
Article
- DOI
10.1038/nrc1622